Polaryx Therapeutics, Inc. S-1
Accession 0001213900-25-113249
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 20, 7:16 PM ET
Size
25.5 MB
Accession
0001213900-25-113249
Documents
- S-1ea0251239-04.htmPrimary
REGISTRATION STATEMENT
- EX-3.1ea025123904ex3-1_polaryx.htm
CERTIFICATE OF INCORPORATION OF THE REGISTRANT, AS CURRENTLY IN EFFECT
- EX-3.2ea025123904ex3-2_polaryx.htm
BYLAWS OF THE REGISTRANT, AS CURRENTLY IN EFFECT
- EX-10.1ea025123904ex10-1_polaryx.htm
POLARYX THERAPEUTICS, INC. 2022 EQUITY INCENTIVE PLAN
- EX-10.2ea025123904ex10-2_polaryx.htm
FORM OF RSU AGREEMENT
- EX-10.3ea025123904ex10-3_polaryx.htm
OFFER LETTER BY AND BETWEEN POLARYX THERAPEUTICS, INC. AND G. MICHAEL LANDIS
- EX-10.4ea025123904ex10-4_polaryx.htm
OFFER LETTER BY AND BETWEEN POLARYX THERAPEUTICS, INC. AND LISA L. BOLLINGER
- EX-10.5ea025123904ex10-5_polaryx.htm
FORM OF POLARYX THERAPEUTICS, INC. 2025 EQUITY INCENTIVE PLAN
- EX-10.6ea025123904ex10-6_polaryx.htm
LICENSE AGREEMENT, DATED APRIL 6, 2016, BETWEEN RUSH UNIVERSITY MEDICAL CENTER AND POLARYX THERAPEUTICS, INC
- EX-10.7ea025123904ex10-7_polaryx.htm
LICENSE AGREEMENT
- EX-10.8ea025123904ex10-8_polaryx.htm
NOVATION AGREEMENT
- EX-10.9ea025123904ex10-9_polaryx.htm
MASTER SERVICES AGREEMENT
- EX-10.10ea025123904ex10-10_polaryx.htm
CONSULTANCY AGREEMENT, DATED NOVEMBER 30, 2021, BETWEEN MSTONE PARTNERS HEALTHCARE LIMITED AND POLARYX THERAPEUTICS, INC.
- EX-10.11ea025123904ex10-11_polaryx.htm
ADDENDUM TO CONSULTANCY AGREEMENT, DATED JUNE 1, 2023, BY AND BETWEEN MSTONE PARTNERS HEALTHCARE LIMITED AND POLARYX THERAPEUTICS, INC.
- EX-10.12ea025123904ex10-12_polaryx.htm
LETTER AGREEMENT, DATED MAY 31, 2023, BY AND BETWEEN MSTONE PARTNERS HEALTHCARE LIMITED AND POLARYX THERAPEUTICS, INC.
- EX-23.2ea025123904ex23-2_polaryx.htm
CONSENT OF GRANT THORNTON LLP
- EX-99.1ea025123904ex99-1_polaryx.htm
CONSENT OF MITCHEL BERGER TO BE NAMED AS A DIRECTOR NOMINEE
- EX-99.2ea025123904ex99-2_polaryx.htm
CONSENT OF CHARLES RYAN TO BE NAMED AS A DIRECTOR NOMINEE
- EX-99.3ea025123904ex99-3_polaryx.htm
CONSENT OF FRANCIS A. BRAUN TO BE NAMED AS A DIRECTOR NOMINEE
- EX-FILINGea025123904ex-fee_polaryx.htm
FILING FEE TABLE
- GRAPHICtpolaryx_logo.jpg
GRAPHIC
- GRAPHICtimage_001.jpg
GRAPHIC
- GRAPHICtimage_002.jpg
GRAPHIC
- GRAPHICtimage_0021.jpg
GRAPHIC
- GRAPHICtimage_003.jpg
GRAPHIC
- GRAPHICtimage_004.jpg
GRAPHIC
- GRAPHICtimage_005.jpg
GRAPHIC
- GRAPHICtimage_006.jpg
GRAPHIC
- GRAPHICtimage_007.jpg
GRAPHIC
- GRAPHICtimage_008.jpg
GRAPHIC
- GRAPHICtimage_009.jpg
GRAPHIC
- GRAPHICtimage_010.jpg
GRAPHIC
- GRAPHICtimage_011.jpg
GRAPHIC
- GRAPHICtimage_012.jpg
GRAPHIC
- GRAPHICtimage_013.jpg
GRAPHIC
- GRAPHICtimage_014.jpg
GRAPHIC
- GRAPHICtimage_015.jpg
GRAPHIC
- GRAPHICtimage_016.jpg
GRAPHIC
- GRAPHICtimage_017.jpg
GRAPHIC
- GRAPHICtimage_018.jpg
GRAPHIC
- GRAPHICtimage_019.jpg
GRAPHIC
- GRAPHICtimage_020.jpg
GRAPHIC
- GRAPHICtimage_021.jpg
GRAPHIC
- GRAPHICtimage_022.jpg
GRAPHIC
- GRAPHICtimage_023.jpg
GRAPHIC
- GRAPHICtimage_024.jpg
GRAPHIC
- GRAPHICtimage_025.jpg
GRAPHIC
- GRAPHICtimage_026.jpg
GRAPHIC
- GRAPHICtimage_027.jpg
GRAPHIC
- GRAPHICtimage_028.jpg
GRAPHIC
- GRAPHICtimage_029.jpg
GRAPHIC
- GRAPHICtimage_030.jpg
GRAPHIC
- GRAPHICtimage_031.jpg
GRAPHIC
- GRAPHICtimage_032.jpg
GRAPHIC
- GRAPHICtimage_033.jpg
GRAPHIC
- GRAPHICtimage_034.jpg
GRAPHIC
- GRAPHICtimage_035.jpg
GRAPHIC
- GRAPHICtimage_036.jpg
GRAPHIC
- GRAPHICex10-3_001.jpg
GRAPHIC
- GRAPHICex10-4_001.jpg
GRAPHIC
- GRAPHICex10-12_001.jpg
GRAPHIC
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLR2.htm
IDEA: XBRL DOCUMENT
- XMLR3.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-113249-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea025123904ex-fee_polaryx_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Polaryx Therapeutics, Inc.
CIK 0002075320
Related Parties
1- filerCIK 0002075320
Filing Metadata
- Form type
- S-1
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 20, 7:16 PM ET
- Size
- 25.5 MB